Co-Diagnostics Inc Sustainability Reports
Co-Diagnostics, Inc. develops, manufactures, and sells reagents used for diagnostic tests that function via the detection and analysis of nucleic acid molecules. The company offers molecular tools for the detection of infectious diseases, agricultural applications, and liquid biopsy for cancer screening.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300Z1JPESYWFM1R93
FIGI: BBG004HTR2F9
2 reports from 2021 to 2023
